Using PIK3CB and connexin-43 inhibition to sensitize pediatric glioblastoma cells to temozolomide.

Abstract

e13572Background: Glioblastoma (GBM) is one of the most common high grade gliomas in pediatric patients, accounting for 2.8% of central nervous system tumors. Standard of care for glioblastoma incl...